Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteomic signatures as biomarkers of atherosclerosis burden.

Cardiovascular research·2026
Same author

Transcriptome analysis in osteoarthritis primary tissues identifies high-confidence effector genes.

Nature communications·2026
Same author

The causal association between sleep traits and osteoarthritis traits: evidence from bidirectional mendelian randomization.

Human molecular genetics·2026
Same author

Genetics of osteoarthritis: Insights from GWAS to therapeutic opportunities.

Osteoarthritis and cartilage·2026
Same author

Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome.

Cell·2026
Same author

HistoGWAS: an AI-enabled framework for automated genetic analysis of tissue phenotypes in histology cohorts.

Genome biology·2026
Same journal

Dual functional genomics reveals a broad and convergent landscape of asciminib resistance in BCR::ABL1.

Genome medicine·2026
Same journal

ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistance.

Genome medicine·2026
Same journal

Cell type-specific contextualisation of the human phenome: towards the systematic treatment of all rare diseases.

Genome medicine·2026
Same journal

Tumor-naïve ctDNA detection with deep learning-enhanced error suppression for sensitive mutation calling.

Genome medicine·2026
Same journal

Microbial cell-free DNA for rapid pathogen identification in clinical diagnostics: a proof of concept study.

Genome medicine·2026
Same journal

VariantMedium: sensitive and generalizable somatic point mutation calling with 3D DenseNets trained and evaluated on experimental data.

Genome medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 2, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Testing for rare variant associations in complex diseases.

Jennifer Asimit1, Eleftheria Zeggini

  • 1Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1HH, UK. ja11@sanger.ac.uk.

Genome Medicine
|May 6, 2011
PubMed
Summary
This summary is machine-generated.

Investigating rare genetic variants using advanced sequencing can explain missing heritability in complex traits. New analytical methods aim to identify risk and protective variants, improving our understanding of disease causes.

More Related Videos

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Related Experiment Videos

Last Updated: Jun 2, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Area of Science:

  • Genetics
  • Genomics
  • Complex Trait Analysis

Background:

  • Complex traits exhibit significant heritability that remains unexplained by common variants.
  • Next-generation sequencing (NGS) technologies allow for comprehensive analysis of genetic variation across all allele frequencies.
  • Rare genetic variants are increasingly recognized as potential contributors to the missing heritability.

Purpose of the Study:

  • To explore the potential of rare variants in explaining the heritability of complex traits.
  • To introduce and evaluate novel analytical approaches for detecting rare risk and protective variants.
  • To highlight the implications of identifying rare risk variants for understanding disease etiopathogenesis.

Main Methods:

  • Utilizing next-generation sequencing to capture genetic variation across the full allele frequency spectrum.
  • Applying advanced statistical and computational methods for the analysis of rare variants.
  • Evaluating a recently proposed approach by Ionita-Laza et al. for its capacity to detect risk and protective variants.

Main Results:

  • Rare variants represent a promising avenue for accounting for missing heritability in complex traits.
  • The application of NGS enables detailed examination of genetic variation.
  • A novel analytical approach demonstrates theoretical potential for identifying risk and protective rare variants.

Conclusions:

  • The study of rare variants is crucial for a complete understanding of complex trait heritability.
  • Advanced sequencing and analytical methods are key to uncovering the role of rare variants.
  • Identifying rare risk variants has significant implications for deciphering the etiology of complex diseases.